|
|
Exchange: |
N/A |
Security
Type: |
Common |
Shares
Out: |
49,310,000 |
Market
Cap: |
449.71(M) |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$9.12 - $9.12 |
|
Level
I Sector: |
N/A |
Level
II Sector: |
N/A |
Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
0 |
0 |
0 |
0 |
Total Sell Value |
$0 |
$0 |
$0 |
$0 |
Total People Sold |
0 |
0 |
0 |
0 |
Total Sell Transactions |
0 |
0 |
0 |
0 |
End Date |
2024-06-23 |
2024-03-22 |
2023-09-22 |
2022-09-22 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Novo A/s |
SEE REMARKS |
|
2014-02-18 |
4 |
A |
$0.00 |
$0 |
D/D |
1,090,823 |
1,090,823 |
|
- |
|
Versant Development Fund Iii, L.p. |
10% Owner |
|
2014-02-18 |
4 |
B |
$13.00 |
$23,478 |
I/I |
1,806 |
3,206,807 |
1.5 |
- |
|
Versant Development Fund Iii, L.p. |
10% Owner |
|
2014-02-18 |
4 |
B |
$13.00 |
$3,976,518 |
D/D |
305,886 |
3,205,001 |
2.45 |
- |
|
Versant Development Fund Iii, L.p. |
10% Owner |
|
2014-02-18 |
4 |
A |
$0.00 |
$0 |
I/I |
371,009 |
2,899,115 |
|
- |
|
Versant Development Fund Iii, L.p. |
10% Owner |
|
2014-02-18 |
4 |
A |
$0.00 |
$0 |
D/D |
2,422,326 |
2,896,838 |
|
- |
|
Tordjman Rafael |
Director |
|
2014-02-18 |
4 |
B |
$13.00 |
$2,999,997 |
I/I |
230,769 |
2,105,491 |
2.25 |
- |
|
Tordjman Rafael |
Director |
|
2014-02-18 |
4 |
A |
$0.00 |
$0 |
I/I |
1,874,722 |
1,874,722 |
|
- |
|
Sofinnova Partners Sas |
10% Owner |
|
2014-02-18 |
4 |
B |
$13.00 |
$2,999,997 |
D/D |
230,769 |
2,105,491 |
2.45 |
- |
|
Sofinnova Partners Sas |
10% Owner |
|
2014-02-18 |
4 |
A |
$0.00 |
$0 |
D/D |
1,874,722 |
1,874,722 |
|
- |
|
Colella Samuel D |
Director |
|
2014-02-18 |
4 |
B |
$13.00 |
$3,999,996 |
I/I |
307,692 |
3,206,807 |
2.25 |
- |
|
Colella Samuel D |
Director |
|
2014-02-18 |
4 |
A |
$0.00 |
$0 |
I/I |
2,793,335 |
2,899,115 |
|
- |
|
Pfizer Inc |
10% Owner |
|
2014-02-18 |
4 |
A |
$0.00 |
$0 |
D/D |
1,687,250 |
1,687,250 |
|
- |
|
Schwab Andrew J. |
Director |
|
2014-02-18 |
4 |
A |
$0.00 |
$0 |
I/I |
1,499,777 |
1,512,076 |
|
- |
|
Bolzon Bradley J Phd |
Director |
|
2014-02-18 |
4 |
B |
$13.00 |
$3,999,996 |
I/I |
307,692 |
3,206,807 |
2.25 |
- |
|
Bolzon Bradley J Phd |
Director |
|
2014-02-18 |
4 |
A |
$0.00 |
$0 |
I/I |
2,793,335 |
2,899,115 |
|
- |
|
Clayman Michael D. |
President and CEO |
|
2014-02-18 |
4 |
A |
$0.00 |
$0 |
I/I |
356,703 |
388,683 |
|
- |
|
Bodick Neil |
Chief Medical Officer |
|
2014-02-18 |
4 |
A |
$0.00 |
$0 |
I/I |
356,703 |
388,683 |
|
- |
|
5am Co-Investors Ii Lp |
10% Owner |
|
2014-02-18 |
4 |
A |
$0.00 |
$0 |
I/I |
1,499,777 |
1,512,076 |
|
- |
|
Fratamico Arthur |
Chief Business OfficerOfficer |
|
2014-02-11 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
48,054 |
|
- |
|
Bodick Neil |
Chief Medical OfficerOfficer |
|
2014-02-11 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
31,980 |
|
- |
|
Bodick Neil |
Chief Medical OfficerOfficer |
|
2014-02-11 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
86,937 |
|
- |
|
Colella Samuel D |
Director |
|
2014-02-11 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
105,780 |
|
- |
|
Clayman Michael D. |
President and CEOOfficer |
|
2014-02-11 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
56,580 |
|
- |
|
Clayman Michael D. |
President and CEOOfficer |
|
2014-02-11 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
273,661 |
|
- |
|
Bolzon Bradley J Phd |
Director |
|
2014-02-11 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
105,780 |
|
- |
|
279 Records found
|
|
Page 11 of 12 |
|
|